蓝丰生化：股东闻勤顺为拟减持不超过3%

Core Viewpoint - Hainan Wenqin Private Fund Management Partnership (Limited Partnership) plans to reduce its stake in Lanfeng Biochemical by up to 11.2678 million shares, representing 3% of the company's total share capital, within three months from the announcement date [1] Summary by Relevant Sections - Shareholding Details - The shareholder currently holds 23.7934 million shares, which accounts for 6.3349% of the total share capital of the company [1] - Reduction Plan - The reduction will occur through centralized bidding and block trading, with a maximum of 1% reduction through centralized bidding and 2% through block trading [1]